Bioanalytical services for small molecule drug development
Our experts can quickly develop, validate, and implement bioanalytical LC-MS, GC-MS, and ICP-MS assays for small- and large-molecule drugs, biomarkers, and elements in compliance with regulatory standards.
Broad range of platforms
- Liquid chromatography with mass spectrometry (LC-MS)
- Inductively coupled plasma mass spectrometry (ICP-MS)
- Gas chromatography with mass spectrometry (GC-MS)
High-resolution mass spectrometry
- Liquid chromatography with ion-trap mass spectrometry (LC-TRAP-MS)
- Liquid chromatography with time-of-flight mass spectrometry (LC-TOF-MS)
Global compliance and regulatory
- Good Laboratory Practice (GLP)- and Good Clinical Practice (GCP)-accredited laboratories
- US Food and Drug Administration (FDA)
- European Medicines Agency (EMA)
- UK Medicines and Healthcare products Regulatory Agency (MHRA)
Specialist areas of expertise
- Insulin analogues and polypeptide drugs
- Elemental analysis
- Volatile drugs and biomarkers